Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FNTA | P49354 | 20/20 | 1.00 |
| ▸ | FNTB | P49356 | 19/20 | 1.00 |
| ▸ | PGGT1B | P53609 | 4/20 | 1.00 |
| ▸ | NRAS | P01111 | 1/20 | 0.47 |
| ▸ | HRAS | P01112 | 1/20 | 0.47 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL445627 | 1.00 | FNTA (1.00) | FNTAFNTBPGGT1BNRASHRAS | |
| SCHEMBL445625 | 1.00 | FNTA (1.00) | FNTAFNTBPGGT1BNRASHRAS | |
| SCHEMBL445938 | 0.94 | FNTA (0.88) | FNTAFNTBPGGT1BNRASHRAS | |
| SCHEMBL445940 | 0.94 | FNTA (0.88) | FNTAFNTBPGGT1BNRASHRAS | |
| Hydrochloric Acid SCHEMBL9083203 | 0.93 | FNTA (0.87) | FNTAFNTBPGGT1BNRASHRAS | |
| Hydrochloric Acid SCHEMBL9083210 | 0.93 | FNTA (0.87) | FNTAFNTBPGGT1BNRASHRAS | |
| SCHEMBL9082830 | 0.92 | FNTA (0.84) | FNTAFNTBPGGT1BNRASHRAS | |
| SCHEMBL9082833 | 0.92 | FNTA (0.84) | FNTAFNTBPGGT1BNRASHRAS | |
| SCHEMBL3499541 | 0.90 | FNTA (0.82) | FNTAFNTBPGGT1BNRASHRAS | |
| SCHEMBL3499539 | 0.90 | FNTA (0.82) | FNTAFNTBPGGT1BNRASHRAS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250114350-A1 | INHIBITORS OF PRENYLTRANSFERASES AS ANTIFUNGAL AGENTS | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2025-04-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250114350-A1 | INHIBITORS OF PRENYLTRANSFERASES AS ANTIFUNGAL AGENTS | FNTA, FNTB, FDPS | FNTA 1/4885FNTB 2/4885PGGT1B 27/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.